NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.25B
This Quarter Return
+2.75%
1 Year Return
+16.85%
3 Year Return
+85.16%
5 Year Return
+142.35%
10 Year Return
+320.31%
AUM
$386M
AUM Growth
+$386M
(+7.4%)
Cap. Flow
+$17.4M
Cap. Flow
% of AUM
4.5%
Top 10 Holdings %
Top 10 Hldgs %
30.83%
Holding
152
New
9
Increased
70
Reduced
28
Closed
10
Top Buys
| 1 |
Cigna
CI
|
$1.49M |
| 2 |
TJX Companies
TJX
|
$1.49M |
| 3 |
CVS Health
CVS
|
$1.27M |
| 4 |
Wells Fargo
WFC
|
$1.19M |
| 5 |
AB InBev
BUD
|
$1.18M |
Top Sells
| 1 |
Ventas
VTR
|
$2.55M |
| 2 |
Philip Morris
PM
|
$1.11M |
| 3 |
SEP
Spectra Engy Parters Lp
SEP
|
$935K |
| 4 |
Molson Coors Class B
TAP
|
$863K |
| 5 |
Acuity Brands
AYI
|
$741K |
Sector Composition
| 1 | Technology | 12.23% |
| 2 | Financials | 12.12% |
| 3 | Materials | 11.91% |
| 4 | Healthcare | 10.57% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$368B
| $4.21M | 1.09% |
48,245
+10,405
| +27% | +$907K |
|
27
SPDR Gold Trust
GLD
$107B
| $4.18M | 1.08% |
35,375
+2,750
| +8% | +$325K |
|
28
Novartis
NVS
$245B
| $4.17M | 1.08% |
49,960
+1,950
| +4% | +$163K |
|
29
Goldman Sachs
GS
$226B
| $4.04M | 1.05% |
18,225
+295
| +2% | +$65.5K |
|
|
30
Philip Morris
PM
$260B
| $4.03M | 1.04% |
34,290
-9,420
| -22% | -$1.11M |
|
31
Altria Group
MO
$113B
| $4.01M | 1.04% |
53,850
+9,050
| +20% | +$674K |
|
32
IBM
IBM
$227B
| $3.94M | 1.02% |
25,630
+1,450
| +6% | +$223K |
|
33
PepsiCo
PEP
$204B
| $3.81M | 0.99% |
33,020
+4,540
| +16% | +$524K |
|
|
34
AB InBev
BUD
$122B
| $3.76M | 0.97% |
34,040
+10,675
| +46% | +$1.18M |
|
35
Boeing
BA
$177B
| $3.73M | 0.97% |
18,850
+3,750
| +25% | +$742K |
|
36
Lockheed Martin
LMT
$106B
| $3.69M | 0.96% |
13,280
| – | – |
|
37
NXP Semiconductors
NXPI
$59.2B
| $3.6M | 0.93% |
32,865
+1,870
| +6% | +$205K |
|
38
Blackstone
BX
$134B
| $3.53M | 0.91% |
105,705
-150
| -0.1% | -$5K |
|
39
Exelon
EXC
$44.1B
| $3.47M | 0.9% |
96,205
| – | – |
|
|
OA
40
DELISTED
Orbital ATK, Inc.
OA
| $3.43M | 0.89% |
34,890
+5,325
| +18% | +$524K |
|
41
Amgen
AMGN
$155B
| $3.43M | 0.89% |
19,910
+50
| +0.3% | +$8.61K |
|
42
RTX Corp
RTX
$212B
| $3.42M | 0.89% |
27,975
+3,525
| +14% | +$430K |
|
43
UnitedHealth
UNH
$281B
| $3.41M | 0.88% |
18,409
-180
| -1% | -$33.4K |
|
|
44
Cigna
CI
$80.3B
| $3.24M | 0.84% |
19,378
+8,920
| +85% | +$1.49M |
|
45
MetLife
MET
$54.1B
| $3.24M | 0.84% |
58,875
-500
| -0.8% | -$27.5K |
|
46
American Express
AXP
$231B
| $3.2M | 0.83% |
37,950
+8,860
| +30% | +$746K |
|
|
NXRT
47
NexPoint Residential Trust
NXRT
$875M
| $3.17M | 0.82% |
127,400
| – | – |
|
48
Enterprise Products Partners
EPD
$69.6B
| $2.75M | 0.71% |
101,625
+20,125
| +25% | +$545K |
|
49
Qualcomm
QCOM
$173B
| $2.73M | 0.71% |
49,430
+18,290
| +59% | +$1.01M |
|
50
HCA Healthcare
HCA
$94.5B
| $2.69M | 0.7% |
30,855
-5,700
| -16% | -$497K |
|